These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 12649932

  • 1. [Role of chemokines in the HIV infection process].
    Proost P, Schols D.
    Verh K Acad Geneeskd Belg; 2002; 64(6):403-20. PubMed ID: 12649932
    [Abstract] [Full Text] [Related]

  • 2. [Chemokine receptors and its importance in the replication cycle of human immunodeficiency virus: clinical and therapeutic implications].
    Azevedo-Pereira JM, Santos-Costa Q.
    Acta Med Port; 2008; 21(5):497-504. PubMed ID: 19187693
    [Abstract] [Full Text] [Related]

  • 3. Chemokines and chemokine receptors in HIV infection: role in pathogenesis and therapeutics.
    Suresh P, Wanchu A.
    J Postgrad Med; 2006; 52(3):210-7. PubMed ID: 16855325
    [Abstract] [Full Text] [Related]

  • 4. CXCR4-tropic HIV-1 suppresses replication of CCR5-tropic HIV-1 in human lymphoid tissue by selective induction of CC-chemokines.
    Ito Y, Grivel JC, Chen S, Kiselyeva Y, Reichelderfer P, Margolis L.
    J Infect Dis; 2004 Feb 01; 189(3):506-14. PubMed ID: 14745709
    [Abstract] [Full Text] [Related]

  • 5. Roles of chemokines and chemokine receptors in HIV-1 infection.
    Murakami T, Yamamoto N.
    Int J Hematol; 2000 Dec 01; 72(4):412-7. PubMed ID: 11197206
    [Abstract] [Full Text] [Related]

  • 6. CXCR4 and CCR5 regulation and expression patterns on T- and monocyte-macrophage cell lineages: implications for susceptibility to infection by HIV-1.
    Joly M, Pinto JM.
    Math Biosci; 2005 May 01; 195(1):92-126. PubMed ID: 15893340
    [Abstract] [Full Text] [Related]

  • 7. HIV chemokine receptor inhibitors as novel anti-HIV drugs.
    Princen K, Schols D.
    Cytokine Growth Factor Rev; 2005 Dec 01; 16(6):659-77. PubMed ID: 16005254
    [Abstract] [Full Text] [Related]

  • 8. Pouncing on the chemokine receptor Chimera.
    Mascolini M.
    J Int Assoc Physicians AIDS Care; 1997 Aug 01; 3(8):13-24. PubMed ID: 11364629
    [Abstract] [Full Text] [Related]

  • 9. CXCR4 and CCR5 expression on CD4+ T cells in vivo and HIV-1 antigen beta-chemokine production in vitro after treatment with HIV-1 immunogen (REMUNE).
    Moss RB, Giermakowska WK, Diveley JP, Savary JR, Wallace MR, Maigetter RZ, Jensen FC, Carlo DJ.
    J Hum Virol; 2000 Aug 01; 3(1):44-9. PubMed ID: 10774806
    [Abstract] [Full Text] [Related]

  • 10. R5 HIV gp120-mediated cellular contacts induce the death of single CCR5-expressing CD4 T cells by a gp41-dependent mechanism.
    Blanco J, Barretina J, Clotet B, Esté JA.
    J Leukoc Biol; 2004 Oct 01; 76(4):804-11. PubMed ID: 15258189
    [Abstract] [Full Text] [Related]

  • 11. The role of the CD4 receptor versus HIV coreceptors in envelope-mediated apoptosis in peripheral blood mononuclear cells.
    Arthos J, Cicala C, Selig SM, White AA, Ravindranath HM, Van Ryk D, Steenbeke TD, Machado E, Khazanie P, Hanback MS, Hanback DB, Rabin RL, Fauci AS.
    Virology; 2002 Jan 05; 292(1):98-106. PubMed ID: 11878912
    [Abstract] [Full Text] [Related]

  • 12. Dichotomous effects of C-C chemokines in HIV-1 pathogenesis.
    Ansari AW, Heiken H, Moenkemeyer M, Schmidt RE.
    Immunol Lett; 2007 May 15; 110(1):1-5. PubMed ID: 17434211
    [Abstract] [Full Text] [Related]

  • 13. Chemokine receptors and mechanisms of cell death in HIV neuropathogenesis.
    Gabuzda D, Wang J.
    J Neurovirol; 2000 May 15; 6 Suppl 1():S24-32. PubMed ID: 10871762
    [Abstract] [Full Text] [Related]

  • 14. Macrophages and lymphocytes differentially modulate the ability of RANTES to inhibit HIV-1 infection.
    Gross E, Amella CA, Pompucci L, Franchin G, Sherry B, Schmidtmayerova H.
    J Leukoc Biol; 2003 Nov 15; 74(5):781-90. PubMed ID: 12960233
    [Abstract] [Full Text] [Related]

  • 15. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
    Irlbeck DM, Amrine-Madsen H, Kitrinos KM, Labranche CC, Demarest JF.
    AIDS; 2008 Jul 31; 22(12):1425-31. PubMed ID: 18614865
    [Abstract] [Full Text] [Related]

  • 16. Structure-function studies of the HIV-1 coreceptors.
    Berson JF, Doms RW.
    Semin Immunol; 1998 Jun 31; 10(3):237-48. PubMed ID: 9653050
    [Abstract] [Full Text] [Related]

  • 17. The epidemiology of HIV coreceptor tropism.
    Hoffmann C.
    Eur J Med Res; 2007 Oct 15; 12(9):385-90. PubMed ID: 17933718
    [Abstract] [Full Text] [Related]

  • 18. Characterization of HIV-2 chimeric viruses unable to use CCR5 and CXCR4 coreceptors.
    Santos-Costa Q, Mansinho K, Moniz-Pereira J, Azevedo-Pereira JM.
    Virus Res; 2009 Jun 15; 142(1-2):41-50. PubMed ID: 19200444
    [Abstract] [Full Text] [Related]

  • 19. Peripheral blood-derived CD34+ progenitor cells: CXC chemokine receptor 4 and CC chemokine receptor 5 expression and infection by HIV.
    Ruiz ME, Cicala C, Arthos J, Kinter A, Catanzaro AT, Adelsberger J, Holmes KL, Cohen OJ, Fauci AS.
    J Immunol; 1998 Oct 15; 161(8):4169-76. PubMed ID: 9780190
    [Abstract] [Full Text] [Related]

  • 20. The role of cholesterol and sphingolipids in chemokine receptor function and HIV-1 envelope glycoprotein-mediated fusion.
    Ablan S, Rawat SS, Viard M, Wang JM, Puri A, Blumenthal R.
    Virol J; 2006 Dec 22; 3():104. PubMed ID: 17187670
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.